Safety and Immune Response of One Dose of OVX836 at Two Dose Levels, in Comparison to Influvac TetraTM, After Intramuscular Administration in Healthy Subjects Aged 18-65 Years
Clinical trial NCT04192500 · COMPLETED
Trial details
- NCT number
- NCT04192500
- Sponsor
- Osivax
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-12-11
- Primary completion
- 2020-09-07
- Enrollment
- 300
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.